CORDIS · 101126492 · HORIZON
NANOBIO4CAN Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer
Coordinator: SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM (TR)
NANOBIO4CAN is a new collaborative research & training programme of excellence for the recruitment of 24 postdoctoral fellows in the field of Nanobiotechnologies for Innovative Therapeutic Approaches for Cancer led by Sabanci University Nanotechnology Research and Application Center (SUNUM) in collaboration with 3 leading Turkish research centers in life sciences: TUBITAK Marmara Research Center (TUBITAK-MAM), Ko University Research Center for Translational Medicine (KUTTAM) and Izmir Biomedicine and Genome Center (IBG).NANOBIO4CAN focuses on cancer research while providing a tailor-made acce…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
0 EU contribution: €2.3M awarded to the consortium. The project runs over approximately 5 years from 2023-11-01 to 2028-10-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from TR
see all →- CoCirculation3 — CO-FUNDED Brain Circulation 3101179377 · HORIZON · €9.6M
- TEAM-NANO — Teaming for Capacity Development and Synergies in Micro-nanofabrication and Flexible Electronics for Widespread Impact101136388 · HORIZON · €9.0M
- SHEREC — SAFE, HEALTHY AND ENVIRONMENTAL SHIP RECYCLING101136056 · HORIZON · €8.0M
- CoCirculation2 — CO-FUNDED Brain Circulation Scheme 2801509 · H2020 · €6.2M
- DIAMETER — Demonstration of a sustainable circular-by-design manufacturing system based on additive manufacturing101177422 · HORIZON · €6.0M
- HSMonitor — Pre-commercial Procurement of innovative ICT-enabled monitoring to improve health status and optimise hypertension care856698 · H2020 · €5.9M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-TMA-MSCA-Cofund-P funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.3M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-MSCA-2022-COFUND-01.
- Who coordinates the project?
- The project is coordinated by SABANCI UNIVERSITESI NANOTEKNOLOJI ARASTIRMA VE UYGULAMA MERKEZI SUNUM (TR).
- What is the project timeline?
- The project runs from 2023-11-01 to 2028-10-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101126492.